Table 2.
Cohort | Full Cohort | SOFA <6 | SOFA 6–8 | SOFA 9–11 | SOFA ⩾12 | P Value* |
---|---|---|---|---|---|---|
All patients | 4.7% | 2.9% | 22.8% | 29.4% | 33.8% | <0.001 |
COVID-19–positive patients | 11.3% | 6.3% | 50.7% | 65.6% | 78.6% | <0.001 |
Race and ethnicity | ||||||
Non-Hispanic White | 15.1% | 6.6% | 76.2% | 50.0% | 100.0% | <0.001 |
Hispanic White | 11.9% | 7.4% | 46.9% | 70.6% | 83.3% | <0.001 |
Non-Hispanic Black | 6.2% | 4.0% | 29.6% | 33.3% | 0.0% | <0.001 |
Hispanic Black | 6.8% | 1.8% | 75.0% | n/a | n/a | <0.001 |
COVID-19–negative patients | 4.0% | 2.5% | 18.3% | 25.6% | 30.6% | <0.001 |
Race and ethnicity | ||||||
Non-Hispanic White | 3.2% | 2.1% | 18.1% | 25.3% | 14.3% | <0.001 |
Hispanic White | 4.4% | 2.7% | 20.1% | 25.5% | 36.3% | <0.001 |
Non-Hispanic Black | 3.3% | 2.0% | 13.1% | 40.7% | 34.5% | <0.001 |
Hispanic Black | 4.2% | 1.9% | 23.1% | 42.9% | 66.7% | <0.001 |
Definition of abbreviations: COVID-19 = coronavirus disease; SOFA = sequential organ failure assessment.
Chi-square testing to determine overall effect of SOFA on mortality for each grouping.